Provided by Tiger Trade Technology Pte. Ltd.

Surrozen, Inc.

30.98
+1.033.44%
Post-market: 29.50-1.4800-4.78%16:54 EDT
Volume:104.48K
Turnover:3.22M
Market Cap:355.86M
PE:-0.96
High:31.53
Open:29.89
Low:29.89
Close:29.95
52wk High:33.96
52wk Low:5.90
Shares:11.49M
Float Shares:5.12M
Volume Ratio:0.73
T/O Rate:2.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-32.3651
EPS(LYR):-32.3700
ROE:-62.80%
ROA:-35.75%
PB:-1.90
PE(LYR):-0.96

Loading ...

Surrozen grants inducement stock option for 2,020 shares at $28.14 each

Reuters
·
9 hours ago

Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
9 hours ago

TD Cowen Initiates Surrozen at Buy

MT Newswires Live
·
Apr 21

Surrozen Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS
·
Apr 21

Analysts’ Top Healthcare Picks: Surrozen (SRZN), Establishment Labs Holdings (ESTA)

TIPRANKS
·
Apr 21

Surrozen initiated with a Buy at TD Cowen

TIPRANKS
·
Apr 21

Surrozen announces annual stockholder meeting via webcast

Reuters
·
Apr 02

Surrozen Inc: Enters Sales Agreement to Sell up to $50 Mln of Common Stock From Time to Time - SEC Filing

THOMSON REUTERS
·
Mar 31

LifeSci Capital Keeps Their Buy Rating on Surrozen (SRZN)

TIPRANKS
·
Mar 28

TCG Crossover GP II reports Surrozen common share acquisition; value rises to $3,007,000

Reuters
·
Mar 26

Guggenheim Keeps Their Buy Rating on Surrozen (SRZN)

TIPRANKS
·
Mar 25

Cantor Fitzgerald Sticks to Their Buy Rating for Surrozen (SRZN)

TIPRANKS
·
Mar 24

Surrozen Price Target Raised to $36.00/Share From $32.00 by HC Wainwright & Co.

Dow Jones
·
Mar 24

Surrozen price target raised to $36 from $32 at H.C. Wainwright

TIPRANKS
·
Mar 24

U.S. RESEARCH ROUNDUP-Apogee Therapeutics, Insmed, Sunoco

Reuters
·
Mar 24

Surrozen Files $200 Million Mixed Shelf

MT Newswires Live
·
Mar 24

Surrozen files $200M mixed securities shelf

TIPRANKS
·
Mar 24

CORRECTED-Biotech firm Surrozen 2025 revenue drops sharply, net loss widens

Reuters
·
Mar 24

Surrozen Q4 EPS $(20.13) Misses $(1.08) Estimate, Sales $500.000K Inline

Benzinga
·
Mar 24

Surrozen FY 2025 net loss widens to USD 242 million as R&D expense rises 39% to USD 29 million

Reuters
·
Mar 24